UBS Group AG - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 28 filers reported holding APTEVO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$28
-99.2%
85
-94.1%
0.00%
Q4 2022$3,318
+231.8%
1,430
+232.6%
0.00%
Q3 2022$1,000
-75.0%
430
-61.2%
0.00%
Q2 2022$4,000
-84.0%
1,107
-65.5%
0.00%
Q4 2021$25,000
-39.0%
3,212
+76.4%
0.00%
Q2 2021$41,000
+272.7%
1,821
+485.5%
0.00%
Q4 2020$11,000
-83.6%
311
-96.5%
0.00%
Q3 2020$67,000
-19.3%
8,848
-11.7%
0.00%
Q2 2020$83,000
+93.0%
10,015
-13.3%
0.00%
Q1 2020$43,00011,5480.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$39,477,0007.86%
RTW INVESTMENTS, LP 281,402$6,312,0000.10%
KENNEDY CAPITAL MANAGEMENT LLC 187,995$4,217,0000.09%
Anson Funds Management LP 35,587$798,0000.08%
Alyeska Investment Group, L.P. 139,172$3,122,0000.04%
Dynamic Technology Lab Private Ltd 14,022$315,0000.03%
JBF Capital, Inc. 3,907$88,0000.02%
BOOTHBAY FUND MANAGEMENT, LLC 15,350$344,0000.01%
Renaissance Technologies 159,923$3,587,0000.00%
QS Investors, LLC 15,650$352,0000.00%
View complete list of APTEVO THERAPEUTICS INC shareholders